Dermal Research Peptides • Regenerative Research Peptides
KLOW Blend
$120.00$120.00
● In stock
KLOW Blend is a research peptide blend supplied as a single lyophilized preparation containing four synthetic peptides: GHK-Cu (Glycyl-Histidyl-Lysine copper complex, 57.87 mg), BPC-157 (pentadecapeptide, 11.66 mg), KPV (Lys-Pro-Val tripeptide, 9.99 mg), and full-length Thymosin β4 (43-amino-acid peptide, also referred to as TB-500, 11.70 mg) — 80 mg labeled size, 91.22 mg net peptide content per COA. Research Use Only — not for human or veterinary use.
Product Name
KLOW Blend
Also Known As
KLOW; KLOW peptide blend; KLOW research blend; KLOW 80mg
Composition
GHK-Cu + BPC-157 + KPV + Thymosin β4 (four-component synthetic peptide blend)
Component Ratios (per COA lot Klow-044-TPL)
GHK-Cu 57.87 mg · BPC-157 11.66 mg · KPV 9.99 mg · Thymosin β4 11.70 mg
Labeled Size
80 mg (nominal)
Net Peptide Content per Vial (COA)
91.22 mg (sum of components)
Overall Preparation Purity
99.685% (HPLC with UV detection, coupled with LC-MS/MS)
Appearance
Blue lyophilized powder (color derives from the Cu²⁺ chelate of GHK-Cu)
Solubility
Soluble in water / aqueous buffer
Storage (lyophilized)
-20°C, sealed, protected from light/moisture
Storage (reconstituted)
2–8°C short-term; aliquot & freeze -20°C; avoid freeze-thaw
Synthesis
Each component synthesized independently by SPPS
Testing Lab
Freedom Diagnostics, USA
Principal Chemist (on COA)
Stephen Schmidt
Test Methods
HPLC with UV detection at 214 nm; identity by LC-MS/MS
Lot Number
Klow-044-TPL
Accession Number (COA)
2601130119
Shipped From
USA
For laboratory research use only. Not for human or veterinary
consumption. This product should only be handled by qualified
professionals.
Product information
KLOW Blend is a four-component synthetic peptide blend supplied as a single lyophilized preparation. The four components — GHK-Cu (a copper-binding tripeptide, CAS 89030-95-5, present at 57.87 mg per vial), BPC-157 (a synthetic pentadecapeptide, CAS 137525-51-0, present at 11.66 mg per vial), KPV (the Lys-Pro-Val tripeptide corresponding to residues 11–13 of α-melanocyte-stimulating hormone, CAS 67727-97-3, present at 9.99 mg per vial), and full-length Thymosin β4 (a 43-amino-acid peptide, CAS 77591-33-4, present at 11.70 mg per vial; also referred to in the research-peptide market by the synonym TB-500) — are synthesized independently by solid-phase peptide synthesis (SPPS) and characterized individually by HPLC (purity, 214 nm UV detection) and LC-MS/MS (identity) prior to blending. This product is supplied as a blue lyophilized powder — the blue color derives from the Cu²⁺ chelate present in the GHK-Cu component. The lot referenced here (Klow-044-TPL) has a documented overall preparation purity of 99.685% and a total net peptide content of 91.22 mg per vial across the four components (labeled 80 mg nominal). Third-party characterization was performed by Freedom Diagnostics (USA). The product is intended exclusively for in-vitro laboratory research and analytical applications. The four components appear across separate strands of the peer-reviewed literature: GHK-Cu is referenced in extracellular matrix and dermal research (originally characterized in the laboratory of Loren Pickart at UCSF); BPC-157 is referenced in gastrointestinal and connective-tissue in-vivo model research (originally characterized in the laboratory of Predrag Sikirić at the University of Zagreb); KPV is referenced in α-MSH-fragment and anti-inflammatory receptor research; and full-length Thymosin β4 is referenced in cytoskeletal actin-binding and tissue-model research.